Advertisement

Amino Acids

, Volume 45, Issue 2, pp 369–381 | Cite as

Optimization of hydrolysis conditions, isolation, and identification of neuroprotective peptides derived from seahorse Hippocampus trimaculatus

  • Ratih Pangestuti
  • BoMi Ryu
  • SWA. Himaya
  • Se-Kwon Kim
Original Article

Abstract

Hippocampus trimaculatus is one of the most heavily traded seahorse species for traditional medicine purposes in many countries. In the present study, we showed neuroprotective effects of peptide derived from H. trimaculatus against amyloid-β42 (Aβ42) toxicity which are central to the pathogenesis of Alzheimer’s diseases (AD). Firstly, H. trimaculatus was separately hydrolyzed by four different enzymes and tested for their protective effect on Aβ42-induced neurotoxicity in differentiated PC12 cells. Pronase E hydrolysate exerted highest protection with cell viability value of 88.33 ± 3.33 %. Furthermore, we used response surface methodology to optimize pronase E hydrolysis conditions and found that temperature at 36.69 °C with the hydrolysis time 20.01 h, enzyme to substrate (E/S) ratio of 2.02 % and pH 7.34 were the most optimum conditions. Following several purification steps, H. trimaculatus-derived neuroprotective peptides (HTP-1) sequence was identified as Gly-Thr-Glu-Asp-Glu-Leu-Asp-Lys (906.4 Da). HTP-1 protected PC12 cells from Aβ42-induced neuronal death with the cell viability value of 85.52 ± 2.22 % and up-regulated pro-survival gene (Bcl-2) expressions. These results suggest that HTP-1 has the potential to be used in treatment of neurodegenerative diseases, particularly AD. Identification, characterization, and synthesis of bioactive components derived from H. trimaculatus have the potential to replace or at least complement the use of seahorse as traditional medicine, which further may become an approach to minimize seahorse exploitation in traditional medicine.

Keywords

H. trimaculatus 42 PC12 RSM Pronase E HTP-1 

Notes

Acknowledgments

This study was supported by a Grant from marine Bioprocess Research Centre of the Marine Biotechnology funded by the Ministry of Land, Transport, and Maritime, Republic of Korea.

Conflict of interest

The authors declare that there are no conflicts of interest.

References

  1. Aneiros A, Garateix A (2004) Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J Chromatogr B 803:41–53CrossRefGoogle Scholar
  2. Aoac (1997) Methods of analysis. Association of Official Analytical Chemists, Washington DCGoogle Scholar
  3. Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, Gozes I (2003) The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24:1413–1423PubMedCrossRefGoogle Scholar
  4. Bhaskar N, Benila T, Radha C, Lalitha R (2008) Optimization of enzymatic hydrolysis of visceral waste proteins of Catla (Catla catla) for preparing protein hydrolysate using a commercial protease. Bioresource technol 99:335–343CrossRefGoogle Scholar
  5. Chabeaud A, Dutournié P, Guérard F, Vandanjon L, Bourseau P (2009) Application of response surface methodology to optimise the antioxidant activity of a saithe (Pollachius virens) hydrolysate. Mar Biotechnol 11:445–455PubMedCrossRefGoogle Scholar
  6. Christensen DZ, Bayer TA, Wirths O (2010) Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer’s disease. Neurobiol Aging 31:1153–1163PubMedCrossRefGoogle Scholar
  7. Cornelly V, Gruppen H, De Bont D, Voragen AGJ (2002) Optimisation of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int Dairy J 12:813–820CrossRefGoogle Scholar
  8. Gozes I (2001) Neuroprotective peptide drug delivery and development: potential new therapeutics. Trends Neurosci 24:700–705PubMedCrossRefGoogle Scholar
  9. Guan J, Thomas GB, Lin H, Mathai S, Bachelor DC, George S, Gluckman PD (2004) Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adults rat. Neuropharmacol 47:892–903CrossRefGoogle Scholar
  10. Hevia P, Olcott HS (1977) Flavor of enzyme-solubilized fish protein concentrate fractions. J Agric Food Chem 25:772–775CrossRefGoogle Scholar
  11. Hsu KC (2010) Purification of antioxidative peptides prepared from enzymatic hydrolysates of tuna dark muscle by-product. Food Chem 122:42–48CrossRefGoogle Scholar
  12. Je JY, Qian ZJ, Kim SK (2007) Antioxidant peptide isolated from muscle protein of bullfrog, Rana catesbeiana shaw. J Medicin Fod 10:401–407CrossRefGoogle Scholar
  13. Kim SK, Wijesekara I (2010) Development and biological activities of marine-derived bioactive peptides: a review. J Func Food 2:1–9CrossRefGoogle Scholar
  14. Kim SK, Byun HG, Park PJ, Shahidi F (2001a) Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J Agric Food Chem 49:2992–2997PubMedCrossRefGoogle Scholar
  15. Kim SK, Kim Y, Byun HG, Nam KS, Joo DS, Shahidi F (2001b) Isolation and characterization of antioxidative peptides from gelatin hydrolysate of Alaska pollack skin. J Agric Food Chem 49:1984–1989PubMedCrossRefGoogle Scholar
  16. Laferla FM, Green KN, Oddo S (2007) Intracellular amyloid-β in Alzheimer’s disease. Nat Rev Neurosci 8:499–509PubMedCrossRefGoogle Scholar
  17. Li Y, Qian ZJ, Kim SK (2008) Cathepsin B inhibitory activities of three new phthalate derivatives isolated from seahorse, Hippocampus Kuda Bleeler. Bioorg Medic Chem Lett 18:6130–6134CrossRefGoogle Scholar
  18. Lin Q, Lin J, Lu J, Li B (2008) Biochemical composition of six seahorse species, Hippocampus sp., from the Chinese coast. J World Aquacult Soc 39:225–234CrossRefGoogle Scholar
  19. Lin Q, Lin J, Wang C (2009) Biochemical composition of the wild and cultured seahorses, Hippocampus kuda Bleeker and Hippocampus trimaculatus Leach. Aquacult Res 40:710–719CrossRefGoogle Scholar
  20. Lourie SA, Pritchard JC, Casey SP, Truong SIKY, Hall HJ, Vincent ACJ (1999) The taxonomy of Vietnam’s exploited seahorses (family Syngnathidae). Biol J Linn Soc 66:231–256CrossRefGoogle Scholar
  21. Mattson MP, Magnus T (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7:278–294Google Scholar
  22. Margioris AN, Markogiannakis E, Makrigiannakis A, Gravanis A (1992) PC12 rat pheochromocytoma cells synthesize dynorphin. Its secretion is modulated by nicotine and nerve growth factor. Endocrinol 131:703–739CrossRefGoogle Scholar
  23. Mullally MM, O’callaghan DM, Fitzgerald RJ, Donnelly WJ, Dalton JP (1995) Zymogen activation in pancreatic endoproteolytic preparations and influence on some whey protein hydrolysate characteristics. J Food Sci 60:227–233CrossRefGoogle Scholar
  24. Pangestuti R, Kim SK (2011) Neuroprotective effects of marine algae. Mar Drugs 9:803–818PubMedCrossRefGoogle Scholar
  25. Payne MF, Rippingale RJ (2000) Rearing West Australian seahorse, Hippocampus subelongatus, juveniles on copepod nauplii and enriched artemia. Aquacult 188:353–361CrossRefGoogle Scholar
  26. Rajapakse N, Kim M, Mendis E, Kim S (2008) Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264. 7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-B signaling. Immunology 123:348–357PubMedCrossRefGoogle Scholar
  27. Ren J, Zhao M, Shi J, Wang J, Jiang Y, Cui C, Kakuda Y, Xue SJ (2008) Optimization of antioxidant peptide production from grass carp sarcoplasmic protein using response surface methodology. LWT-Food Sci Technol 41:1624-1632Google Scholar
  28. Resende R, Ferreiro E, Pereira C, Resende De Oliveira C (2008) Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neurosci 155:725–737CrossRefGoogle Scholar
  29. Ryu BM, Qian ZJ, Kim SK (2010) Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-[kappa] B activation, and induces human osteoblastic and chondrocytic differentiation. Chem Biol Interact 184:413–422PubMedCrossRefGoogle Scholar
  30. Vincent ACJ, Foster SJ, Koldewey HJ (2011) Conservation and management of seahorses and other Syngnathidae. J Fish Biol 78:1681–1724PubMedCrossRefGoogle Scholar
  31. Wijesinghe WAJP, Jeon YJ (2011) Enzyme-assistant extraction (EAE) of bioactive components: a useful approach for recovery of industrially important metabolites from seaweeds: a review. Fitoterapia 83:6–12PubMedCrossRefGoogle Scholar
  32. Zhang N, Xu B, Mou C, Yang W, Wei J, Lu L, Zhu J, Du J, Wu X, Ye L, Fu Z, Lu Y, Lin J, Sun Z, Su J, Dong M, Xu A (2003) Molecular profile of the unique species of traditional Chinese medicine, Chinese seahorse (Hippocampus kuda Bleeker). FEBS Lett 550:124–134PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Ratih Pangestuti
    • 1
  • BoMi Ryu
    • 1
    • 3
  • SWA. Himaya
    • 2
  • Se-Kwon Kim
    • 1
    • 2
  1. 1.Marine Bioprocess Research CenterPukyong National UniversityBusanSouth Korea
  2. 2.Marine Biochemistry Laboratory, Department of ChemistryPukyong National UniversityBusanSouth Korea
  3. 3.School of PharmacyThe University of QueenslandBrisbaneAustralia

Personalised recommendations